Obesity and T2D mellitus are commonly seen in subjects with NAFLD and it is well appreciated that excessive accumulation of lipids (i.e., “lipotoxicity) in the liver, skeletal muscle, and pancreatic beta cells can drive the overproduction of insulin and insulin resistance in target tissues (38, 39, 40). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.